Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Patient and equipment profile for wheelchair seating clinic provision.
Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.
Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children.
A Pilot Study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
[Retinal vasculitis as manifestation of multiple sclerosis.]
Early accurate diagnosis crucial in multiple sclerosis.
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
Structural Biology of the S1P1 Receptor.
Spasticity in multiple sclerosis: results of a patient survey.
Diagnosis and classification of autoimmune optic neuropathy.
Quality improvement and practice-based research in neurology using the electronic medical record.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
Cognition and eye movements: assessment of cerebral dysfunction.
Understanding Drivers of Employment Changes in a Multiple Sclerosis Population.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Mind-body medicine for multiple sclerosis: a systematic review.
The Gut Microbiome and the Brain.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Progressive multiple sclerosis: pathology and pathogenesis.
Imaging of glutamate in the spinal cord using GluCEST.
Defining the new end point for multiple sclerosis treatment.
Pages
« first
‹ previous
…
263
264
265
266
267
268
269
270
271
…
next ›
last »